Prognostic Significance of Total Lymphocyte Count, Neutrophil-to-lymphocyte Ratio, and Platelet-to-lymphocyte Ratio in Limited-stage Small-cell Lung Cancer

Ryoko Suzuki, Xiong Wei, Pamela K. Allen, James D. Cox, Ritsuko Komaki, Steven H. Lin

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Abstract

We sought markers of survival and disease control among patients treated for limited-stage small-cell lung cancer. High pretreatment total lymphocyte count was linked with superior (and high neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios with inferior) median and 2-year overall survival, findings confirmed in multivariate Cox regression. Baseline lymphopenia was an indicator of poor prognosis in patients with limited-stage small-cell lung cancer.

Original languageEnglish (US)
Pages (from-to)117-123
Number of pages7
JournalClinical Lung Cancer
Volume20
Issue number2
DOIs
StatePublished - Mar 2019

Keywords

  • Chemoradiation
  • Lymphopenia
  • Neutrophil-to-lymphocyte ratio
  • Overall survival
  • Small cell lung cancer

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Fingerprint

Dive into the research topics of 'Prognostic Significance of Total Lymphocyte Count, Neutrophil-to-lymphocyte Ratio, and Platelet-to-lymphocyte Ratio in Limited-stage Small-cell Lung Cancer'. Together they form a unique fingerprint.

Cite this